These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33528651)

  • 1. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective and subjective outcomes of strabismus surgery in Graves' orbitopathy: a prospective multicentre study.
    Jellema HM; Saeed P; Mombaerts I; Dolman PJ; Garrity J; Kazim M; Dhrami-Gavazi E; Lyons C; Nieuwkerk P; Mourits MP
    Acta Ophthalmol; 2017 Jun; 95(4):386-391. PubMed ID: 28133945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multidisciplinary Thyroid Eye Clinic: A One-stop Shop.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Winter H; Huna-Baron R; Wygnanski-Jaffe T; Ben Simon G
    Isr Med Assoc J; 2022 Oct; 24(10):671-676. PubMed ID: 36309864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in clinical presentation and prognosis of thyroid eye disease.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Eur J Ophthalmol; 2021 Sep; 31(5):2717-2723. PubMed ID: 33158379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ; Jang SY; Lim TH; Yoon JS
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
    Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
    Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
    Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
    [No Abstract]   [Full Text] [Related]  

  • 9. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients in a combined thyroid eye clinic in secondary care.
    Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
    Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease.
    Fayers T; Fayers PM; Dolman PJ
    Orbit; 2016 Dec; 35(6):328-334. PubMed ID: 27599688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
    Son BJ; Lee SY; Yoon JS
    Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
    Dietrich A; Taylor P; White P; Wilson V; Uddin J; Lee RWJ; Dayan C; Jackson S;
    Psychol Health Med; 2018; 23(sup1):1341-1355. PubMed ID: 30092670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
    Cockerham KP; Padnick-Silver L; Stuertz N; Francis-Sedlak M; Holt RJ
    Ophthalmol Ther; 2021 Dec; 10(4):975-987. PubMed ID: 34478126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.
    Villagelin D; Romaldini J; Andrade J; Santos R; Milkos A; Teixeira PFDS; Ward LS
    Front Endocrinol (Lausanne); 2019; 10():192. PubMed ID: 31024443
    [No Abstract]   [Full Text] [Related]  

  • 18. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
    Sawicka-Gutaj N; Bednarczuk T; Daroszewski J; Waligórska-Stachura J; Miśkiewicz P; Sowiński J; Bolanowski M; Ruchała M
    Endokrynol Pol; 2015; 66(4):362-6. PubMed ID: 26323474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial.
    Hoppe E; Lee ACH; Hoppe D; Kahaly GJ
    Eur Thyroid J; 2021 Feb; 9(6):313-320. PubMed ID: 33718255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves' orbitopathy.
    Stoynova MA; Shinkov AD; Dimitrova ID; Yankova IA; Kovatcheva RD
    Int Ophthalmol; 2024 Feb; 44(1):68. PubMed ID: 38347322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.